Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Cameron Harrison and Tom Layton
Conrad Harrison (l) and Thomas Layton (r) both received the prestigious Hunterian Professorships

Named after the pioneering surgeon and scientist John Hunter and dating back over two centuries, the Hunterian Professorship is among the most highly-regarded annual awards in the field of surgery.

Conrad Harrison, NIHR Doctoral Research Fellow at NDORMS has been awarded the Hunterian Professorship for his work on on outcome measurement in plastic surgery.

Conrad joined the University of Oxford in 2015 where he completed Academic Foundation and Core Surgical Training programmes. He holds an honorary contract with Oxford University Hospitals as a Specialty Registrar in Plastic and Reconstructive Surgery and has taken time out of clinical training to complete a DPhil. His research uses contemporary data science to improve the way we measure health outcomes.

Hunterian Professors are invited to give an annual Hunterian Lecture on their field of specialism and chosen research. Conrad will deliver his Hunterian lecture entitled ‘Transforming outcome measures in plastic surgery’ at the British Association of Plastic Reconstructive and Aesthetic Surgeons (BAPRAS) winter meeting on 1 December. 

Thomas Layton, Postdoctoral Clinical Research Fellow at the Kennedy Institute, was also awarded a 2022 Hunterian Professorship for his work on Dupuytren's disease.

Thomas studied Medicine at the University of Manchester before his foundation training in Oxford where he completed an Oxford-Celgene research fellowship working towards a DPhil in Cell and Molecular Biology.  He is now doing his core surgical training in Oxford and continuing his collaboration with BMS-Celgene as supervisor of a postdoctoral research fellowship aiming to explore and uncover central regulators of human liver fibrosis.

Tom’s Hunterian lecture ‘The single cell landscape of Dupuytren’s disease’ builds on his DPhil, which utilised advanced single cell technologies including CyTOF and scRNA-seq to define key molecular and cellular pathways governing fibrosis in Dupuytren's disease. His lecture will also be delivered at the BAPRAS meeting on 2 December.

Similar stories

Connects-UK launches to foster scientific collaborations between EU and UK researchers in a post-Brexit era

Connects-UK, a new pan-European network dedicated to advancing scientific collaborations between researchers in the European Union (EU) and the United Kingdom (UK), was officially launched at an event in London yesterday. The network, led by a diaspora of EU researchers working in the UK, seeks to bridge the gap created by Brexit and ensure that collaboration, innovative research, funding, and knowledge exchange continue to thrive in the post-Brexit era.